This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Mcmaster University, Tel Aviv University. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2024
Title: Galina F Denisova: Innovator in T Cell Engineering
Introduction
Galina F Denisova is a prominent inventor based in Hamilton, Canada. She has made significant contributions to the field of immunology, particularly in the engineering of T cells for enhanced therapeutic applications. With a total of seven patents to her name, her work is paving the way for advancements in cancer treatment and immune response modulation.
Latest Patents
Denisova's latest patents include a groundbreaking invention titled "T cell-antigen coupler with Y182T mutation and methods of uses thereof." This trifunctional molecule comprises a target-specific ligand, a ligand that binds a protein associated with the T cell receptor (TCR) complex, and a T cell receptor signaling domain polypeptide. The ligand that binds a protein associated with the TCR complex is UCHT1 with a Y182T mutation. Engineering T cells with this novel receptor engenders antigen-specific activation of numerous T cell functions, including cytokine production, degranulation, and cytolysis.
Career Highlights
Denisova's career is marked by her innovative research and development in T cell engineering. Her work has not only resulted in multiple patents but has also contributed to the understanding of T cell functions and their potential applications in immunotherapy. She is affiliated with McMaster University, where she continues to advance her research.
Collaborations
Throughout
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile